Lexaria Bioscience Corp (LEXX)
2.23
+0.02
(+0.90%)
USD |
NASDAQ |
Dec 20, 16:00
2.22
-0.01
(-0.45%)
After-Hours: 20:00
Lexaria Bioscience Market Cap: 38.92M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals Inc | 1.293B |
| Edesa Biotech Inc | 5.722M |
| Xenon Pharmaceuticals Inc | 2.950B |
| ESSA Pharma Inc | 71.02M |
| ImmunoPrecise Antibodies Ltd | 12.43M |
Market Cap Related Metrics
| PS Ratio | 59.30 |
| Price to Book Value | 4.843 |
| Price | 2.23 |
| Earnings Yield | -21.08% |